The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a technique that could help advance ...

Alarm bells are again ringing in Brazil, The country might have impressive foreign trade figures and surpluses, but Brazil ...

Money flows out of Harvard into biotechs, housing projects, and retail storefronts. The school powers hospitals, tourism, and ...

Analysis - Artificial Intelligence (AI) is redefining the foundations of global economies, governance, industries, and social structures.

- Mr. Grasman brings over two decades of biotech financial leadership experience - ...

Quanzhou Grand Pacific Chemical is a key investment for GPPC in entering the C3 value chain. Quanzhou Grand Pacific Chemical Achieves Mass ...

EES is one of 37 divisions at the NSF; the divisions make up the agency’s eight directorates. Both NSF employees that C&EN ...

Shenzhen's latest move underscores its strategy to leverage state-backed capital to support the semiconductor sector China's ...

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

Fast-forward 10 years and step into 2035. Imagine your morning ritual with the Daily FT. Forget passively “reading”; in a ...